U.S. Orthopedic Rehabilitation Devices Market to $7.32B

Market Outlook

The U.S. Orthopedic Rehabilitation Devices Market is projected to reach approximately USD 7.32 billion by 2032, expanding at a CAGR of 9.35% during the forecast period 2027–2032. The market is valued at USD 4.28 billion in 2026, with historical analysis covering 2023 to 2025. Values throughout this report are expressed in USD billions.

The market expanded from approximately USD 3.41 billion in 2023 to USD 3.65 billion in 2024 and USD 3.95 billion in 2025, supported by rising orthopedic procedure volumes, growing prevalence of osteoarthritis and mobility impairment, expansion of outpatient orthopedic care, and increasing use of rehabilitation technologies after joint replacement, ligament reconstruction, fracture repair, and spine procedures. Based on the forecast trajectory, the market is positioned to advance to approximately USD 4.68 billion in 2027, USD 5.12 billion in 2028, USD 5.60 billion in 2029, USD 6.12 billion in 2030, USD 6.69 billion in 2031, and USD 7.32 billion by 2032.

Orthopedic rehabilitation has become strategically more important within U.S. musculoskeletal care because clinical success is increasingly measured beyond the surgical episode. Hospitals, orthopedic groups, physical therapy networks, ambulatory surgery centers, payers, and patients are placing greater emphasis on restoration of function, time to mobility, return to work, avoidance of complications, and prevention of repeat procedures. This is increasing demand for orthopedic braces and supports, therapeutic exercise systems, electrotherapy equipment, cold and compression devices, joint-mobilization technologies, sensor-enabled rehabilitation platforms, and robotic mobility systems.

The addressable patient pool is structurally large. More than 53 million U.S. adults have diagnosed arthritis, while approximately 33 million adults are affected by osteoarthritis, making degenerative joint disease one of the most important recurring demand drivers for orthopedic rehabilitation. The U.S. population aged 65 years and older has also exceeded 61 million, creating a larger cohort exposed to osteoarthritis, joint replacement, falls, fractures, balance impairment, and age-related mobility decline.

Orthopedic procedure volumes reinforce this demand. The American Joint Replacement Registry has accumulated information on more than 4.4 million hip and knee arthroplasty procedures performed through 2024, illustrating the scale of post-surgical rehabilitation pathways associated with total joint replacement alone. In sports medicine, approximately 200,000 ACL injuries occur annually in the United States, while emergency departments treated approximately 4.4 million sports- and recreation-related injuries in 2024.

The market therefore operates at the intersection of surgical orthopedics, physical therapy, durable medical equipment, home recovery, sports medicine, and digital health. Vendors capable of connecting surgical intervention with rehabilitation protocols, patient adherence, functional measurement, and longitudinal outcomes are positioned to capture disproportionate value through 2032.

Introduction

According to the U.S. Orthopedic Rehabilitation Devices Market Report, orthopedic rehabilitation devices are increasingly becoming an integrated component of the musculoskeletal care pathway rather than an ancillary purchase made after treatment. The market includes products used before surgery to improve functional readiness, immediately after orthopedic intervention to control pain and swelling, throughout supervised physical therapy to restore strength and range of motion, and during home rehabilitation to sustain recovery between clinical visits.

The U.S. market benefits from one of the world’s largest orthopedic treatment infrastructures. The country has more than 6,000 hospitals, approximately 6,400 Medicare-participating ambulatory surgical centers, over 1,100 inpatient rehabilitation facilities reporting to CMS, and more than 12,000 Medicare-registered home health agencies. This creates multiple purchasing environments with distinct economic requirements. Hospitals prioritize clinical outcomes, discharge efficiency, infection control, standardization, and enterprise contracting. Outpatient therapy practices focus on patient throughput, compact equipment footprints, therapist productivity, and reimbursement economics. Home-based care favors portable, connected, easy-to-operate devices.

The rehabilitation workforce also supports market expansion. The United States had approximately 283,700 physical therapist positions in 2025, and physical therapist employment is projected to increase by about 12% between 2025 and 2035. Approximately 13,400 physical therapist openings are expected annually during that period. This workforce expansion reflects the underlying requirement to manage an aging population, rising orthopedic procedure volumes, and chronic mobility impairment.

Procurement is shifting from individual-device purchasing toward care-pathway economics. Orthopedic departments increasingly ask whether a rehabilitation technology can shorten recovery time, reduce unnecessary visits, improve range of motion, support earlier discharge, increase therapy adherence, or allow part of a traditionally supervised rehabilitation program to occur safely at home. Devices capable of producing measurable functional data are gaining strategic importance because they provide clinicians with evidence of progress between encounters.

Another defining feature of the market is outpatient migration. Knee arthroplasty, hip arthroplasty, arthroscopy, ligament reconstruction, shoulder procedures, foot and ankle surgery, and selected spine procedures are increasingly performed in lower-cost outpatient environments when patient selection permits. Rehabilitation therefore starts earlier and occurs across a wider number of settings. Device manufacturers must support a continuum extending from the orthopedic operating room to the physical therapy clinic and ultimately to the patient’s home.

Between 2027 and 2032, the strongest commercial opportunity will come from technologies that combine clinical efficacy with workflow efficiency. Connected braces, portable electrical stimulation, app-linked exercise programs, motion sensors, intelligent resistance systems, remote therapeutic monitoring, robotic gait platforms, and patient-specific orthoses will increase the amount of objective data available during recovery.

Key Market Drivers: What’s Fueling the U.S. Orthopedic Rehabilitation Devices Market Boom?

The first structural driver is the expanding burden of musculoskeletal disease. Approximately 21% of U.S. adults have diagnosed arthritis, translating into more than 53 million people requiring varying levels of pain management, mobility support, strengthening, joint protection, or rehabilitation. Osteoarthritis alone affects about 33 million adults and is especially relevant to the knee, hip, hand, and spine. Because almost half of adults with arthritis are aged 65 years or older, demographic aging compounds the long-term demand opportunity.

The second driver is the scale of orthopedic surgery. Hip and knee arthroplasty remain among the most important procedures generating structured rehabilitation requirements. The U.S. joint replacement registry ecosystem now contains millions of procedures from hospitals, ambulatory surgery centers, and orthopedic groups across all states. Every successful total joint episode requires mobility restoration, gait training, pain management, strengthening, range-of-motion recovery, and adherence to post-operative protocols.

Sports injury is another important demand source. Approximately 200,000 ACL injuries occur each year in the United States, with reconstruction frequently followed by several months of progressive strengthening and functional testing. Sports and recreational activities generated approximately 4.4 million emergency department-treated injuries in 2024, up materially from the previous year. These injuries sustain demand for braces, supports, cryotherapy, compression, electrotherapy, strengthening systems, resistance products, and return-to-play assessment technologies.

Demographic aging is widening the rehabilitation pool beyond elective surgery. The U.S. population aged 65 and older reached approximately 61.2 million in 2024, representing around 18% of the population. More than 14 million older adults report a fall each year, and a substantial proportion experience injuries requiring treatment or activity restriction. Falls generate fractures, joint injuries, deconditioning, fear of movement, and balance deficits that frequently require rehabilitation devices and assisted mobility technologies.

A fourth major driver is the outpatient migration of orthopedic care. More orthopedic procedures are moving into ASCs and hospital outpatient departments because of advances in anesthesia, minimally invasive surgery, patient selection, and standardized recovery protocols. The United States has approximately 6,410 ambulatory surgical centers participating in Medicare, providing an expanding channel through which orthopedic recovery devices can be initiated before patients return home.

A fifth driver is the growing emphasis on therapy productivity. Physical therapy practices face labor constraints while demand continues to rise. Devices that allow therapists to supervise more patients without compromising treatment quality are becoming economically attractive. Automated resistance systems, programmable electrotherapy, objective range-of-motion sensors, digital home exercise platforms, robotic systems, and remotely monitored rehabilitation tools all address this requirement.

A sixth driver is the growing importance of measurable outcomes. Providers and payers increasingly expect documentation around pain reduction, strength restoration, range of motion, walking ability, return to activity, discharge function, and patient-reported outcomes. Rehabilitation technologies capable of turning physical recovery into measurable longitudinal data will have greater value than products that function only as standalone hardware.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in orthopedic rehabilitation is moving from passive support toward active recovery management. The competitive benchmark is no longer simply whether a brace stabilizes a knee or whether an electrical stimulation system activates a muscle. Manufacturers are increasingly expected to demonstrate improved patient compliance, better fitting, faster setup, objective outcome measurement, portability, and seamless use across inpatient, outpatient, and home environments.

Bracing innovation is focused on lighter materials, improved ventilation, simplified fitting, customizable unloading, and greater patient adherence. Advanced knee OA braces redistribute joint loading while maintaining mobility. Post-operative braces increasingly incorporate adjustable range-of-motion control. Spine and scoliosis products are being engineered to balance corrective force with wearability because a clinically effective brace provides little value if patients cannot tolerate prescribed wear times.

Electrotherapy is progressing through more intuitive interfaces, portable treatment platforms, advanced stimulation waveforms, and combination modalities. Electrical stimulation is frequently used in orthopedic rehabilitation to support pain management, neuromuscular re-education, prevention of disuse atrophy, and muscle activation. Systems designed for rapid therapist setup are particularly attractive in high-volume outpatient practices.

Cold therapy and compression are also being redesigned around the outpatient orthopedic pathway. Compact systems that combine controlled cooling with intermittent compression can support recovery after knee, hip, shoulder, ankle, and sports medicine procedures. Manufacturers are increasingly positioning these products as part of standardized perioperative protocols rather than optional comfort devices.

Sensor-enabled rehabilitation represents one of the strongest innovation areas. Inertial measurement units, wearable motion sensors, force measurement, connected braces, and smartphone-based functional assessment allow clinicians to evaluate movement outside the clinic. These technologies can measure joint angles, exercise completion, walking activity, symmetry, and adherence while identifying patients whose recovery is falling behind expected milestones.

Robotic rehabilitation is moving beyond high-cost research installations toward practical clinical workflow applications. Robotic gait systems, powered exoskeletons, body-weight support systems, and automated mobility trainers can allow clinicians to deliver higher-intensity movement repetitions while reducing manual assistance. Although adoption remains concentrated in advanced rehabilitation facilities, improvements in cost, footprint, software, and reimbursement could broaden access during the forecast period.

Artificial intelligence will increasingly sit above these technologies. AI-enabled systems can interpret mobility patterns, identify abnormal recovery trajectories, recommend changes in exercise difficulty, and prioritize which patients require direct therapist intervention. The long-term competitive advantage will belong to manufacturers that integrate devices, clinical protocols, patient engagement, and outcome analytics rather than selling isolated pieces of equipment.

Segmentation Insights

The U.S. Orthopedic Rehabilitation Devices Market is segmented on the basis of product type, anatomical area, clinical application, end user, technology, and region.

By Product Type

Orthopedic Braces and Supports

Orthopedic braces and supports represent the largest product category, accounting for approximately 31.8% of the 2026 market structure. The category includes knee braces, ankle supports, spinal orthoses, shoulder immobilizers, wrist and hand supports, walking boots, post-operative range-of-motion braces, and osteoarthritis unloading systems.

Demand is anchored by more than 53 million adults with diagnosed arthritis, 33 million adults with osteoarthritis, approximately 200,000 annual ACL injuries, and substantial post-operative orthopedic volumes. Knee bracing represents the highest-value subcategory because of the combination of osteoarthritis, sports injury, ligament reconstruction, and total joint recovery.

Therapeutic Exercise and Strengthening Equipment

Therapeutic exercise and strengthening systems account for approximately 21.2% of market demand. Products include resistance systems, therapeutic tables, exercise platforms, balance devices, pulley systems, pedal exercisers, strength-training devices, and functional movement equipment.

The category is closely linked to the U.S. physical therapy workforce, which included approximately 283,700 physical therapists in 2025. With therapist employment projected to grow 12% through 2035, clinics are increasingly investing in equipment capable of supporting repeatable, measurable rehabilitation protocols while maximizing usable treatment space.

Electrotherapy and Pain-Management Systems

Electrotherapy represents approximately 16.4% of market value and includes neuromuscular electrical stimulation, transcutaneous electrical nerve stimulation, interferential therapy, therapeutic ultrasound, combination therapy systems, and related accessories.

U.S. demand is strongest in outpatient therapy, sports medicine, pain management, post-operative orthopedic care, and home rehabilitation. The FDA regulates electrical muscle stimulators as medical devices, and most cleared systems used therapeutically are positioned within supervised physical therapy and rehabilitation pathways.

Cold, Heat and Compression Therapy

Cold, heat, and compression products account for approximately 12.6% of demand. The segment includes circulating cold therapy, powered compression systems, reusable cold packs, heat therapy equipment, contrast therapy, and recovery compression devices.

Demand is strongly connected to sports injuries and orthopedic surgery. Approximately 4.4 million sports and recreation-related injuries were treated in U.S. emergency departments during 2024, creating a substantial recurring pool for acute swelling management and recovery support.

Continuous Passive Motion and Joint-Mobilization Systems

CPM and joint-mobilization technologies represent approximately 8.4% of market value. They are used selectively following knee procedures and other orthopedic interventions where controlled motion forms part of the prescribed recovery pathway.

The segment is mature but remains relevant because U.S. hip and knee arthroplasty procedures generate large post-operative rehabilitation volumes. More than 4.4 million procedures with complete information were represented in the 2025 American Joint Replacement Registry report covering procedures through 2024.

Robotic and Sensor-Enabled Rehabilitation Systems

Robotic and sensor-enabled devices account for approximately 9.6% of market value but represent the fastest-growing product category. Systems include robotic gait trainers, exoskeletons, sensor-based exercise systems, connected range-of-motion tools, instrumented rehabilitation platforms, and digitally guided mobility technologies.

The category benefits from more than 1,100 CMS-reporting inpatient rehabilitation facilities, expansion of advanced outpatient rehabilitation networks, and increasing payer interest in measurable functional outcomes.

By Anatomical Area

Knee Rehabilitation

Knee rehabilitation is the dominant anatomical segment, accounting for approximately 34.5% of market demand. Knee osteoarthritis, total knee arthroplasty, ACL injury, meniscus procedures, cartilage repair, patellar disorders, and sports trauma create extensive requirements for braces, electrotherapy, strengthening equipment, cold therapy, ROM systems, and digital rehabilitation.

The approximately 200,000 ACL injuries recorded annually in the United States illustrate the scale of the sports-related component alone.

Hip Rehabilitation

Hip rehabilitation represents approximately 17.8% of market value. Demand is primarily driven by total hip arthroplasty, fracture recovery, mobility decline, falls, and osteoarthritis.

The aging U.S. population is particularly important. More than 61 million Americans are at least 65 years old, while over 14 million older adults report falling annually. Hip rehabilitation therefore spans elective joint replacement, traumatic fracture, gait retraining, balance restoration, and home mobility.

Shoulder Rehabilitation

Shoulder rehabilitation accounts for approximately 14.6% of market demand and includes recovery from rotator cuff repair, shoulder arthroplasty, instability, labral injury, fracture, and overuse conditions.

Relevant devices include immobilizers, range-of-motion equipment, pulley systems, resistance products, electrical stimulation, cold therapy, and sensor-enabled movement assessment. Outpatient physical therapy clinics and orthopedic sports practices dominate utilization.

Spine and Back Rehabilitation

Spine and back rehabilitation contributes approximately 13.2% of demand. Products include spinal braces, lumbar supports, therapeutic exercise systems, electrical stimulation, traction-related equipment, and strengthening devices.

The segment serves patients following spine surgery as well as those experiencing chronic mechanical back pain, deconditioning, postural dysfunction, and occupational musculoskeletal injury. Demand is influenced by both orthopedic and rehabilitation medicine pathways.

Foot and Ankle Rehabilitation

Foot and ankle applications account for approximately 11.1% of market value. Rehabilitation follows ankle sprains, ligament reconstruction, Achilles injuries, fractures, foot surgery, sports injuries, and mobility impairment.

Walking boots, ankle braces, balance systems, resistance products, compression therapy, and functional testing systems represent important subcategories.

Upper Extremity Rehabilitation

Elbow, wrist, hand, and other upper-extremity applications contribute approximately 8.8% of demand. The segment covers fracture rehabilitation, tendon injuries, repetitive strain conditions, post-operative hand therapy, and sports-related trauma.

Products include braces, splints, hand exercise systems, resistance products, electrical stimulation, and range-of-motion technologies.

By Clinical Application

Post-Operative Orthopedic Rehabilitation

Post-operative rehabilitation is the largest application, accounting for approximately 36.5% of market demand. Total joint replacement, arthroscopy, ligament reconstruction, rotator cuff repair, spine surgery, fracture fixation, and foot and ankle surgery generate structured rehabilitation requirements.

The more than 4.4 million procedures represented in the national hip and knee arthroplasty registry demonstrate the scale of just one surgical subset feeding this market.

Osteoarthritis and Degenerative Joint Disease

Osteoarthritis-related rehabilitation contributes approximately 21.2% of demand. Around 33 million U.S. adults live with osteoarthritis, supporting sustained utilization of unloading braces, strengthening systems, mobility products, electrotherapy, and exercise equipment.

This segment is especially important because treatment occurs over years rather than a single episode.

Sports Injury Rehabilitation

Sports rehabilitation accounts for approximately 15.7% of market value. Sports and recreation activities generated about 4.4 million emergency department-treated injuries in 2024.

ACL injuries, ankle sprains, shoulder instability, muscle injuries, tendon disorders, and overuse conditions drive device utilization across school athletics, collegiate sports, professional teams, private sports medicine centers, and outpatient rehabilitation practices.

Fracture and Trauma Rehabilitation

Fracture and trauma represent approximately 11.4% of demand. Older adult falls are particularly significant, with more than 14 million Americans aged 65 and older reporting falls annually.

Orthopedic trauma recovery frequently requires braces, walking aids, progressive loading, strengthening, balance retraining, and home rehabilitation.

Chronic Musculoskeletal Pain

Chronic musculoskeletal pain contributes approximately 9.1% of the market. Demand includes lumbar pain, shoulder disorders, degenerative joint disease, tendinopathy, and persistent post-operative symptoms.

Electrical stimulation, therapeutic exercise, heat, strengthening, supportive bracing, and digital home programs are widely used across multimodal care pathways.

Prosthetic, Orthotic and Mobility Retraining

This application represents approximately 6.1% of market value and includes gait retraining, orthotic adaptation, balance therapy, and functional mobility restoration.

The category is increasingly influenced by advanced prosthetics, robotic gait systems, connected orthoses, and objective mobility assessment.

By End User

Outpatient Physical Therapy and Orthopedic Clinics

Outpatient physical therapy and orthopedic clinics represent the largest end-user group at approximately 31.9% of market demand.

Their importance is increasing as more orthopedic recovery shifts away from inpatient care. Procurement emphasizes durable equipment, rapid patient turnover, compact footprint, treatment versatility, therapist efficiency, and measurable clinical outcomes.

Hospitals and Health Systems

Hospitals account for approximately 24.3% of market demand. The United States has roughly 6,100 hospitals and more than 907,000 staffed beds, providing significant infrastructure for orthopedic surgery, trauma care, inpatient rehabilitation, and early post-operative mobility.

Large systems frequently standardize equipment across multiple facilities and negotiate enterprise-level agreements.

Ambulatory Surgery Centers and Orthopedic Surgical Centers

ASCs and specialty orthopedic surgical facilities contribute approximately 15.4% of market demand. CMS data identify approximately 6,410 ambulatory surgical centers, an infrastructure base increasingly relevant to outpatient joint replacement, arthroscopy, ligament repair, and other orthopedic procedures.

These buyers favor compact recovery products and streamlined discharge pathways.

Home Healthcare and Patient Home Use

Home-based rehabilitation represents approximately 11.6% of demand and is one of the fastest-growing end-user categories.

There are more than 12,000 Medicare-registered home health agencies in the United States, while home health services explicitly include physical and occupational therapy. Portable electrical stimulation, cold therapy, braces, compact exercise devices, connected sensors, and digital rehabilitation platforms are particularly well suited to this environment.

Inpatient Rehabilitation Facilities and Skilled Nursing Facilities

This group accounts for approximately 9.8% of market value. More than 1,100 inpatient rehabilitation facilities report quality information to CMS, while the broader U.S. post-acute infrastructure includes more than 14,000 skilled nursing facilities participating in Medicare.

Demand is concentrated in mobility equipment, gait training, strengthening, balance systems, transfer training, and functional recovery.

Sports Medicine and Athletic Performance Centers

Sports medicine centers contribute approximately 7.0% of demand. Utilization is concentrated in braces, compression recovery systems, cryotherapy, resistance equipment, functional testing, neuromuscular stimulation, and return-to-sport technologies.

By Technology

Mechanical and Non-Powered Devices

Mechanical and non-powered rehabilitation technologies account for approximately 40.7% of market value. Braces, supports, exercise systems, resistance devices, balance equipment, and manual mobility products dominate this category.

The segment maintains strong demand because of relatively low acquisition cost, minimal maintenance, widespread reimbursement familiarity, and broad applicability.

Powered and Electromechanical Systems

Powered and electromechanical devices represent approximately 17.5% of the market. This category includes motorized exercise equipment, CPM systems, powered compression, advanced gait systems, and automated rehabilitation technologies.

Demand is supported by clinics seeking repeatable therapy delivery and reduced manual workload.

Electrical Stimulation Technologies

Electrical stimulation accounts for approximately 16.8% of market demand. Neuromuscular electrical stimulation and related modalities are widely integrated into pain management, muscle activation, strength recovery, and post-operative rehabilitation.

Portable platforms will continue gaining share as rehabilitation migrates into home settings.

Connected Wearable and Sensor Technologies

Connected wearables and sensor systems represent approximately 14.2% of market value and are expected to grow substantially faster than conventional devices.

Wearable sensors can track range of motion, exercise adherence, walking activity, movement quality, and functional progress between appointments, allowing clinicians to intervene more selectively.

Robotic and Exoskeleton Systems

Robotics and exoskeleton technologies contribute approximately 10.8% of market value. Adoption remains concentrated in advanced rehabilitation hospitals and specialized centers because of capital cost and training requirements.

However, clinical demand for higher therapy intensity, objective movement data, reduced manual assistance, and repeatable gait training is strengthening the commercial case for this category.

Regional Insights: Where the Market is Growing Fastest

The U.S. Orthopedic Rehabilitation Devices Market is geographically segmented into the South, Northeast, West, and Midwest. Regional performance varies according to population scale, age distribution, orthopedic surgery volumes, physical therapy infrastructure, sports participation, Medicare exposure, hospital density, prevalence of arthritis and obesity, ASC concentration, and adoption of digital rehabilitation.

The South represents the largest regional market with approximately 37.6% of national demand, while the West is positioned for the fastest expansion through 2032. The Northeast combines high procedure acuity with dense rehabilitation networks, while the Midwest provides a large and durable base of joint replacement, orthopedic surgery, arthritis, and post-acute rehabilitation demand.

South

The South is the largest orthopedic rehabilitation device region and is positioned to grow at approximately 9.6% CAGR through 2032.

The regional footprint includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, West Virginia, Maryland, Delaware, Kentucky, Tennessee, Alabama, Mississippi, Arkansas, Louisiana, Oklahoma, and the District of Columbia, depending on commercial territory definitions.

Texas is one of the most important state markets nationally. Its large population, rapidly growing metropolitan regions, extensive orthopedic surgery base, expanding outpatient infrastructure, and high concentration of sports medicine activity support demand across nearly every rehabilitation category. Houston, Dallas-Fort Worth, Austin, and San Antonio provide large addressable markets for outpatient physical therapy, joint replacement recovery, sports medicine, and hospital-based rehabilitation.

Florida is structurally important because of its older population. The state has approximately 5.1 million residents aged 65 and older, creating a large patient pool for osteoarthritis management, hip and knee rehabilitation, fall-related recovery, balance therapy, and home rehabilitation. Florida’s substantial Medicare population also makes reimbursement alignment particularly important for manufacturers.

North Carolina, Georgia, Tennessee, and Virginia are growing markets because of expanding metropolitan populations, strong health systems, orthopedic specialty practices, and ambulatory care investment. North Carolina combines major academic centers with fast-growing communities around Raleigh-Durham and Charlotte. Tennessee has strong orthopedic and rehabilitation clusters around Nashville and Memphis.

Alabama, Mississippi, Kentucky, West Virginia, Arkansas, and Louisiana present a different commercial opportunity. Chronic musculoskeletal disease, obesity, arthritis, and mobility impairment generate considerable need, but access to specialist rehabilitation can be uneven outside major metropolitan areas. Home-use devices, tele-rehabilitation support, portable electrotherapy, braces, and simple connected technologies can therefore have disproportionate value.

For manufacturers, the South is not a single market. Texas and Florida reward scale and broad distribution; North Carolina, Georgia, Tennessee, and Virginia support premium clinical adoption; rural Southern states create stronger demand for cost-effective technologies capable of extending rehabilitation beyond specialist centers.

West

The West accounts for approximately 20.9% of U.S. market demand and is projected to grow at approximately 10.3% CAGR through 2032, making it the fastest-growing regional market.

The region includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the dominant Western state and one of the most influential orthopedic technology markets nationally. Its large population, academic health systems, orthopedic specialty groups, professional sports ecosystem, digital health sector, and concentration of technology-oriented providers make it an important launch environment for connected rehabilitation technologies.

California buyers are particularly receptive to remote monitoring, sensor-based rehabilitation, digitally guided therapy, recovery analytics, sports-performance systems, and home-based care models when economic evidence is compelling. The state’s high labor costs further increase interest in technologies capable of improving therapist productivity.

Arizona and Nevada are high-growth orthopedic rehabilitation markets because of rapid population growth and large retiree communities. Aging populations increase demand for joint replacement recovery, OA bracing, balance training, gait rehabilitation, and home-based therapy.

Colorado and Utah have strong sports participation, active populations, growing orthopedic specialty groups, and sophisticated rehabilitation networks. These characteristics create favorable demand for sports injury rehabilitation, return-to-activity testing, advanced braces, and recovery devices.

Washington and Oregon support substantial adoption of integrated and connected care models. Large health systems in these states tend to evaluate rehabilitation technology in terms of clinical outcomes, workflow integration, and total care costs.

The West is particularly important to manufacturers developing sensor systems, software-enabled rehabilitation, wearables, robotic technologies, and digitally connected home recovery platforms.

Northeast

The Northeast represents approximately 22.8% of national market demand and is expected to expand at approximately 8.7% CAGR through 2032.

The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Vermont, New Hampshire, Maine, and Delaware under commonly used regional structures.

New York is the largest Northeast market because of its population scale, extensive hospital infrastructure, academic medical centers, orthopedic surgery volumes, and large outpatient rehabilitation ecosystem. Rehabilitation purchasing is frequently influenced by integrated health systems and sophisticated physician groups.

Pennsylvania provides another substantial patient base across Philadelphia, Pittsburgh, and regional health systems. Joint replacement, spine surgery, sports medicine, and post-acute care create broad demand for therapy equipment and orthopedic recovery technologies.

Massachusetts is smaller in population but disproportionately influential because of its academic medical centers, clinical research ecosystem, innovation culture, and highly specialized rehabilitation programs. Manufacturers introducing premium robotic, sensor-enabled, or digitally integrated technologies frequently prioritize such institutions for evaluation and clinical validation.

New Jersey and Connecticut support high-value outpatient orthopedic and rehabilitation networks, while Maine, Vermont, and New Hampshire have relatively older populations and greater geographic dispersion. Portable and home-oriented products can therefore be particularly relevant in northern New England.

Procurement in the Northeast tends to be evidence intensive. Large hospital systems frequently require formal technology assessment, standardized purchasing, health-economic justification, cybersecurity review for connected products, and evidence that devices improve outcomes or staff efficiency.

Midwest

The Midwest accounts for approximately 18.7% of national demand and is positioned to grow at approximately 8.5% CAGR through 2032.

The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois is the largest Midwest market, driven by the Chicago metropolitan area and its concentration of hospitals, orthopedic practices, outpatient rehabilitation providers, sports medicine programs, and post-acute facilities.

Ohio is another important orthopedic care market with substantial health system capacity in Cleveland, Columbus, Cincinnati, and surrounding communities. Joint replacement, spine care, sports medicine, and rehabilitation services support a stable device base.

Michigan and Indiana generate large volumes of musculoskeletal care associated with aging populations, manufacturing workforces, orthopedic surgery, and chronic joint disease. Wisconsin and Minnesota combine mature health systems with sophisticated rehabilitation infrastructure.

Minnesota is also strategically relevant because of its broader medical-device ecosystem. Providers in the state frequently participate in early technology evaluation and outcomes-driven procurement.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota have smaller absolute populations, but rural geography increases demand for technologies capable of supporting rehabilitation outside major medical centers. Portable therapy systems, remote monitoring, home exercise devices, and durable braces can therefore offer meaningful clinical and economic value.

The Midwest will remain a reliable region for manufacturers with strong distribution, competitive contracting, clinician education, and service support. Its growth may be slower than the West and South, but its large orthopedic procedure base and mature provider infrastructure create stable recurring demand.

Key Market Players

The competitive environment is fragmented across orthopedic bracing, physical therapy equipment, recovery sciences, compression therapy, robotics, orthotics, mobility products, and connected rehabilitation. Scale alone does not determine competitive strength. Companies succeed by controlling clinical relationships, distribution, fitting expertise, therapist workflow, reimbursement support, and continuity between clinic and home.

Some of the key players in the U.S. Orthopedic Rehabilitation Devices industry are:

Enovis Corporation
Breg, Inc.
Össur
Ottobock
Thuasne USA
DeRoyal Industries
Hely & Weber
Performance Health
Dynatronics Corporation
Zimmer MedizinSystems
Hyperice
Ekso Bionics
DIH / Hocoma
Medline Industries
Drive DeVilbiss Healthcare

Enovis is strategically important because its DonJoy, Chattanooga, and broader recovery sciences portfolios span orthopedic bracing, cold therapy, electrotherapy, and rehabilitation equipment. Breg maintains a strong position in orthopedic bracing, cold therapy, DME workflow, and integrated orthopedic provider relationships. Össur and Ottobock combine orthotics, bracing, prosthetics, and advanced mobility expertise.

Performance Health, Dynatronics, and Zimmer MedizinSystems participate heavily in clinical rehabilitation equipment and modality-based therapy. Hyperice has developed strong recognition in recovery and compression technology, particularly within sports and active populations.

Ekso Bionics and DIH/Hocoma represent the technology-intensive end of rehabilitation through robotic mobility and advanced rehabilitation systems. Medline and Drive DeVilbiss benefit from broad distribution and access to hospitals, post-acute providers, homecare channels, and rehabilitation customers.

Competitive share through 2032 will increasingly depend on whether companies can support entire recovery pathways rather than single-device purchases. Manufacturers able to provide devices, patient education, digital monitoring, reimbursement support, clinician training, supply-chain reliability, and outcomes data will have an advantage in health-system and orthopedic-group contracting.

Recent Developments

The U.S. orthopedic rehabilitation market is entering a period of accelerated product differentiation. In 2026, Enovis expanded its orthopedic bracing portfolio with the U.S. launch of the DonJoy Spinamic Hybrid Scoliosis Brace. The platform combines rigid corrective elements with a more adjustable and breathable design, illustrating the industry’s broader movement toward improving patient wearability without sacrificing therapeutic function.

Recovery sciences innovation is also accelerating. Enovis has expanded its rehabilitation portfolio through newer Intelect electrotherapy platforms designed to simplify therapist workflow and support electrical stimulation applications across pain management, neuromuscular rehabilitation, and orthopedic recovery. The broader strategic direction is toward easier setup, portable systems, and therapy technologies that can be deployed across both clinics and decentralized care.

Advanced orthotic and exoskeleton technologies are also progressing. Ottobock introduced an intelligent powered back-support exoskeleton platform designed around sensor-based assistance and movement-responsive support. Although industrial exoskeleton use differs from conventional clinical rehabilitation, this development highlights rapid crossover between biomechanical sensing, wearable robotics, orthotics, and musculoskeletal injury prevention.

The clinical evidence base supporting orthopedic recovery is simultaneously becoming deeper. The 2025 American Joint Replacement Registry report analyzed more than 4.4 million hip and knee procedures with complete information collected through 2024. The expansion of large-scale outcome registries is strategically important because hospitals and payers increasingly expect post-operative rehabilitation vendors to demonstrate measurable improvements in function and recovery rather than relying only on product-level performance.

Care delivery infrastructure is also changing. CMS data indicate approximately 6,410 ambulatory surgical centers, 12,182 home health agencies, more than 14,500 skilled nursing facilities, and over 1,100 inpatient rehabilitation facilities across the U.S. care environment. These settings create distinct device requirements and are accelerating development of portable, remotely monitored, and patient-operated rehabilitation technology.

Connected rehabilitation will be one of the most important development themes through 2032. Product development is moving toward integration of exercise adherence, range-of-motion tracking, activity data, gait analysis, patient-reported outcomes, and clinician dashboards. For orthopedic manufacturers, the strategic opportunity is to connect the surgical episode with measurable recovery after discharge.

Conclusion

The U.S. Orthopedic Rehabilitation Devices Market Size & Share is positioned to expand from USD 4.28 billion in 2026 to approximately USD 7.32 billion by 2032, representing a 9.35% CAGR during 2027–2032.

The market’s growth is supported by structural rather than temporary drivers. More than 53 million U.S. adults have diagnosed arthritis, approximately 33 million live with osteoarthritis, the 65-and-older population exceeds 61 million, more than 14 million older adults report falls annually, and approximately 200,000 ACL injuries occur each year. Joint replacement volumes, sports injuries, outpatient orthopedic procedures, and chronic mobility impairment create a recurring requirement for rehabilitation across multiple settings.

The most attractive product opportunities will emerge in advanced orthopedic bracing, portable electrotherapy, compression and cold therapy, connected exercise platforms, wearable movement sensors, robotic rehabilitation, and technologies that extend therapy into the home.

Knee rehabilitation will remain the largest anatomical opportunity because it combines osteoarthritis, total knee replacement, sports ligament injury, and post-operative recovery. Post-operative orthopedic rehabilitation will continue to represent the largest clinical application, while osteoarthritis management provides an exceptionally durable chronic-care opportunity.

Outpatient physical therapy and orthopedic practices will remain the largest device users, but home rehabilitation is expected to gain influence as clinical pathways become more decentralized. Hospitals and health systems will continue to exert substantial purchasing power, particularly where products are standardized across orthopedic service lines.

Regionally, the South will remain the largest market because of its population scale, rapidly growing metropolitan areas, older populations in states such as Florida, and extensive orthopedic infrastructure in Texas and other high-growth states. The West is expected to deliver the fastest expansion because of strong technology adoption, population growth, active lifestyles, and sophisticated digital-health ecosystems. The Northeast will remain highly attractive for premium and evidence-intensive rehabilitation technologies, while the Midwest will provide a durable base of joint replacement, chronic orthopedic disease, and post-acute rehabilitation demand.

For manufacturers, investors, distributors, hospitals, orthopedic groups, and rehabilitation networks evaluating this market, the critical strategic question is increasingly how recovery can be measured, accelerated, and moved into lower-cost settings without compromising outcomes.

Future market leaders will be companies that can combine clinically differentiated hardware with therapist workflow efficiency, patient adherence, reimbursement compatibility, remote monitoring, and real-world evidence. The U.S. orthopedic rehabilitation market is therefore evolving from a collection of braces, modalities, and exercise products into a connected recovery ecosystem in which functional outcomes become the primary measure of value.